cdn mobile

Lapu-Lapu resumes vaccination rollout

By: Futch Anthony Inso - CDN Digital | June 28,2021 - 04:14 PM

LAPU-LAPU CITY, Cebu—The Lapu-Lapu City government has resumed its vaccination rollout on Monday, June 28, 2021, after they receive an additional supply of Coronavirus Disease 2019 (COVID-19) vaccines.

Dr. Agnes Realiza, head of the Lapu-Lapu City Health Department, said that the city has received 4,000 doses of the Sinovac vaccines from the Department of Health in Central Visayas (DOH-7).

The inoculation of the new supply of COVID-19 vaccines will still be done at the Hoops Dome in Barangay Gun-ob and at the City Auditorium in Barangay Poblacion.

On Friday, June 25, the city ran out of supply of first doses of Pfizer vaccines. The city is expected to start inoculation of the second dose of the Pfizer vaccines in July.

Lapu-Lapu City Mayor Junard “Ahong” Chan  revealed that the city is expected to receive an additional supply of the vaccine on Tuesday, June 29, 2021.

“Magpaabot lang ta kung unsa nga bakuna ang moabot,” Chan said.

He said that the current supply of the Sinovac vaccines is expected to last for two days or until Tuesday. /bmjo

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: lapu-lapu, Pfizer, Sinovac, vaccines
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.